Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Financing Cash Flow

$32.24M

TTM · Period ending: · USD

LCTX logo

LCTX Financing Cash Flow

Latest reported$32.24M
LCTX TTM Cash from Financing ($0.00 → $32.24M)
High-resolution chart · PNG

LCTX financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
32,240,000
27,467,000
26,950,000
28,305,000
26,468,000
26,880,000
35,857,000
14,110,000
14,920,000
20,443,000
6,423,000
6,558,000
6,715,000
1,120,000
1,632,000
2,464,000
5,219,000
16,480,000
36,930,000
40,790,000
61,629,000
50,838,000
29,865,000
25,046,000
567,000
1,000
617,000
716,000
782,000
5,747,000
5,774,000
32,059,000
36,906,000
36,927,000
55,391,000
29,855,000
37,071,000
51,115,000
32,782,000
61,483,000
60,434,000
59,855,142
64,775,000
66,204,206
55,503,550
57,178,616
63,623,243
41,776,294
41,317,785
33,278,955
34,263,608
26,764,177
27,036,094
15,026,516
1,913,378
287,285
3,049,833
3,172,583
3,862,414
10,955,945
17,553,434
26,000,999
25,767,456
23,770,894
18,872,444
15,377,352
16,482,966
11,965,627
7,980,989
3,509,189
2,516,895
2,291,469
1,582,768
1,164,545
694,937
339,874
299,874
99,874
0
1,309,458
1,557,286
1,877,286
1,877,160
-3,616,592
-3,864,420
-4,166,113
-1,994,146
2,190,274
2,190,274
2,258,863
86,896
58,820
1,851,566
1,764,670
1,764,670
1,792,734
2,849,988
3,532,860
3,549,360
3,705,561
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.